Blood Pressure Components and the Risk for End-Stage Renal Disease and Death in Chronic Kidney Disease

被引:89
作者
Agarwal, Rajiv [1 ,2 ]
机构
[1] Indiana Univ, Dept Med, Sch Med, Indianapolis, IN 46202 USA
[2] Richard L Roudebush Vet Adm Med Ctr, Indianapolis, IN 46202 USA
来源
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2009年 / 4卷 / 04期
关键词
DIABETIC-NEPHROPATHY TRIAL; PULSE PRESSURE; CARDIOVASCULAR OUTCOMES; SYSTOLIC HYPERTENSION; MORTALITY; PROGRESSION; ASSOCIATION; PREDICTORS; LEVEL;
D O I
10.2215/CJN.06201208
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background and objectives: Mean arterial pressure has been used in clinical trials in nephrology to randomly assign and treat patients, yet the pulsatile component of BP is recognized to influence outcomes in older people. I examined the unique contributions of systolic (SBP) and diastolic BP (DBP) on the risk for ESRD and death in patients with chronic kidney disease (CKD). Design, setting, participants, & measurements: A single-center, prospective cohort study was conducted of 218 veterans with CKD (22% black, 4% women, mean age 68 yr, clinic BP 154.1 +/- 25.1/85.2 +/- 13.9 mmHg, 48% with diabetes). Results: During follow-up of up to 7 yr, 63 patients had ESRD and 102 patients died. Compared with those with controlled SBP (<130 mmHg), patients with moderate control (130 to 149 mmHg) had hazard ratio of 3.87 and those with poor control hazard ratio of 9.09 for ESRD. DBP had no direct ability to predict ESRD. For all-cause mortality, a J-shaped relationship was seen for SBP and an inverse relationship was seen for DBP. Considered jointly in the Cox model, a higher SBP and lower DBP improved the prediction of all-cause mortality compared with either BP component alone. The presence of J curve was especially pronounced in patients with advanced CKD, absence of clinical proteinuria, or age >65 yr. Conclusions: In older patients with CKD, SBP predicts ESRD and a higher SBP and lower DBP predicts all-cause mortality. Lower BP of <110/70 mmHg is a marker of higher mortality in older individuals with advanced CKD.
引用
收藏
页码:830 / 837
页数:8
相关论文
共 32 条
[1]   Correlates of systolic hypertension in patients with chronic kidney disease [J].
Agarwal, R ;
Andersen, MJ .
HYPERTENSION, 2005, 46 (03) :514-520
[2]   Competing risk factor analysis of end-stage renal disease and mortality in chronic kidney disease [J].
Agarwal, Rajiv ;
Bunaye, Zerihun ;
Bekele, Dagim M. ;
Light, Robert P. .
AMERICAN JOURNAL OF NEPHROLOGY, 2008, 28 (04) :569-575
[3]   Prognostic significance of between-arm blood pressure differences [J].
Agarwal, Rajiv ;
Bunaye, Zerihun ;
Bekele, Dagim M. .
HYPERTENSION, 2008, 51 (03) :657-662
[4]  
Agarwal R, 2007, CURR OPIN NEPHROL HY, V16, P409
[5]   Effect of ramipril vs amlodipine on renal outcomes in hypertensive nephrosclerosis - A randomized controlled trial [J].
Agodoa, LY ;
Appel, L ;
Bakris, GL ;
Beck, G ;
Bourgoignie, J ;
Briggs, JP ;
Charleston, J ;
Cheek, D ;
Cleveland, W ;
Douglas, JG ;
Douglas, M ;
Dowie, D ;
Faulkner, M ;
Gabriel, A ;
Gassman, J ;
Greene, T ;
Hall, Y ;
Hebert, L ;
Hiremath, L ;
Jamerson, K ;
Johnson, CJ ;
Kopple, J ;
Kusek, J ;
Lash, J ;
Lea, J ;
Lewis, JB ;
Lipkowitz, M ;
Massry, S ;
Middleton, J ;
Miller, ER ;
Norris, K ;
O'Connor, D ;
Ojo, A ;
Phillips, RA ;
Pogue, V ;
Rahman, M ;
Randall, OS ;
Rostand, S ;
Schulman, G ;
Smith, W ;
Thornley-Brown, D ;
Tisher, CC ;
Toto, RD ;
Wright, JT ;
Xu, SC .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (21) :2719-2728
[6]   Pathogenesis and treatment of kidney disease and hypertension - Home blood pressure monitoring in CKD [J].
Andersen, MJ ;
Khawandi, W ;
Agarwal, R .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2005, 45 (06) :994-1001
[7]   Effects of blood pressure level on progression of diabetic nephropathy - Results from the RENAAL study [J].
Bakris, GL ;
Weir, MR ;
Shanifar, S ;
Zhang, ZX ;
Douglas, J ;
van Dijk, DJ ;
Brenner, BM .
ARCHIVES OF INTERNAL MEDICINE, 2003, 163 (13) :1555-1565
[8]   Cardiovascular outcomes in the Irbesartan Diabetic Nephropathy Trial of patients with type 2 diabetes and overt nephropathy [J].
Berl, T ;
Hunsicker, LG ;
Lewis, JB ;
Pfeffer, MA ;
Porush, JG ;
Rouleau, JL ;
Drury, PL ;
Esmatjes, E ;
Hricik, D ;
Parikh, CR ;
Raz, I ;
Vanhille, P ;
Wiegmann, TB ;
Wolfe, BM ;
Locatelli, F ;
Goldhaber, SZ ;
Lewis, EJ .
ANNALS OF INTERNAL MEDICINE, 2003, 138 (07) :542-549
[9]   J-shaped relationship between blood pressure and mortality in hypertensive patients: New insights from a meta-analysis of individual-patient data [J].
Boutitie, F ;
Gueyffier, F ;
Pocock, S ;
Fagard, R ;
Boissel, JP .
ANNALS OF INTERNAL MEDICINE, 2002, 136 (06) :438-448
[10]   Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy [J].
Brenner, BM ;
Cooper, ME ;
de Zeeuw, D ;
Keane, WF ;
Mitch, WE ;
Parving, HH ;
Remuzzi, G ;
Snapinn, SM ;
Zhang, ZX ;
Shahinfar, S .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (12) :861-869